Title |
Interaction Between SARS-CoV-2 and Pathogenic Bacteria
|
---|---|
Published in |
Current Microbiology, May 2023
|
DOI | 10.1007/s00284-023-03315-y |
Pubmed ID | |
Authors |
Parvindokht Fazel, Hamid Sedighian, Elham Behzadi, Reza Kachuei, Abbas Ali Imani Fooladi |
Abstract |
The novel human coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which results in the coronavirus disease 2019 (COVID-19), has caused a serious threat to global public health. Therefore, many studies are performed on the causes and prevalence of this disease and the possible co-occurrence of the infection with other viral and bacterial pathogens is investigated. Respiratory infections predispose patients to co-infections and these lead to increased disease severity and mortality. Numerous types of antibiotics have been employed for the prevention and treatment of bacterial co-infection and secondary bacterial infections in patients with a SARS-CoV-2 infection. Although antibiotics do not directly affect SARS-CoV-2, viral respiratory infections often result in bacterial pneumonia. It is possible that some patients die from bacterial co-infection rather than virus itself. Therefore, bacterial co-infection and secondary bacterial infection are considered critical risk factors for the severity and mortality rates of COVID-19. In this review, we will summarize the bacterial co-infection and secondary bacterial infection in some featured respiratory viral infections, especially COVID-19. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 2 | 10% |
France | 2 | 10% |
Antarctica | 1 | 5% |
Spain | 1 | 5% |
Ukraine | 1 | 5% |
Colombia | 1 | 5% |
United States | 1 | 5% |
Chile | 1 | 5% |
Canada | 1 | 5% |
Other | 0 | 0% |
Unknown | 10 | 48% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 81% |
Scientists | 3 | 14% |
Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 21% |
Researcher | 2 | 11% |
Other | 1 | 5% |
Student > Ph. D. Student | 1 | 5% |
Unknown | 11 | 58% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 2 | 11% |
Medicine and Dentistry | 2 | 11% |
Business, Management and Accounting | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Immunology and Microbiology | 1 | 5% |
Other | 1 | 5% |
Unknown | 11 | 58% |